Todd Ashworth, B.S., Biochemistry,
Northeastern University, Boston, MA
Ph.D. Student in Immunology
E-mail: todd.ashworth@tufts.edu

The mechanism by which TFII-I functions in B lymphocytes is not fully understood. It was recently demonstrated that Bruton’s tyrosine kinase associates with TFII-I in the cytoplasm. Upon Btk activation, TFII-I is phosphorylated and dissociates from Btk resulting in nuclear translocation of TFII-I and transcription of target genes. The downstream targets and functional effects of TFII-I activation are unknown. Xid mice, which are deficient in Btk, lack the ability to proliferate upon antigenic stimulation and undergo apoptosis as a result. I am studying the in vivo function of TFII-I using RNAi. Briefly, B lymphoma cell lines are infected with retrovirus containing shRNA, which results in knockdown of TFII-I expression. Ultimately, I plan on using RNAi technology to study the function of TFII-I in primary B cells.